← Back to headlines
Medical Journal Retracts Amgen Drug Trial Paper After FDA Findings
A medical journal has retracted a paper detailing the main study for Amgen's drug Tavneos following findings from the FDA. The retraction comes after scrutiny of the trial data.
30 Jun, 07:41 — 30 Jun, 07:41
Coverage Timeline
First report: bloomberg · 29 Jun, 19:00|Full coverage: 2 · 13h|Window: 13h
Left-leaningCenterRight-leaning
